Acquiring Company
Syntagon
Acquired Company
Nanologica
Description
Syntagon has successfully acquired life science company Nanologica. This acquisition comes as Nanologica reported a surge in Q2 sales. The merger aims to enhance Syntagon's capabilities in pharmaceutical development. Both companies are expected to benefit from shared expertise and resources.
Don't miss Syntagon's next move
Get an email the moment Syntagon makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
M&A Insights
Based on deal dataFrequently asked
Who acquired Nanologica?
Nanologica was acquired by Syntagon. The deal was reported on August 31, 2026. Syntagon is a life science firm specializing in development services for pharmaceuticals. They provide comprehensive services from drug development to manufacturing. Syntagon is privately held and operates in Manufacturing.
When did Syntagon acquire Nanologica?
Syntagon's acquisition of Nanologica was reported on August 31, 2026. Syntagon has successfully acquired life science company Nanologica. This acquisition comes as Nanologica reported a surge in Q2 sales. The merger aims to enhance Syntagon's capabilities in pharmaceutical development. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Nanologica do?
Nanologica is a life science company that focuses on developing innovative solutions for drug delivery. They utilize advanced nanotechnology to improve the efficacy of therapeutic compounds. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.